Conmed Corp revenue increases to $295.47 million in quarter ended Mar 31, 2023 from previous quarter
Key fundamental financials
profit of $1.82 million
Revenue of $295.47 million
earnings per share of $0.06
Current Reporting
Revenue
Net Income
Profit/Loss
Mar 2023
$295.47 million
$1.82 million
profit
Sep 2022
$275,088
$46,150
profit
Jun 2022
$277.19 million
$168.29 million
loss
Conmed Corp [CNMD] has reported $1.82 million profit for the fiscal quarter ending Mar 31, 2023 while the earnings for the same period were $0.06 per share.
Revenue for the quarter was $295.47 million with operating income of $12.70 million.
The Utica, Florida (FL)-based company operating in the electromedical & electrotherapeutic apparatus sector has total shareholders equity of $752.45 million.